Switch to:
More From Other Websites
Ocular TherapeutixTM to Present at Three Upcoming Investor Conferences Feb 09 2017
OCULAR THERAPEUTIX, INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other... Jan 25 2017
ETFs with exposure to Ocular Therapeutix, Inc. : January 25, 2017 Jan 25 2017
Ocular Therapeutics Sinks Following Secondary Offering Jan 24 2017
Ocular Therapeutix, Inc. Announces Pricing of Public Offering of Common Stock Jan 24 2017
Ocular Therapeutix, Inc. Announces Public Offering of Common Stock Jan 23 2017
OCULAR THERAPEUTIX, INC Files SEC form 8-K, Other Events Jan 23 2017
Ocular Therapeutix™ Resubmits NDA for DEXTENZA™ for the Treatment of Ocular Pain Occurring After... Jan 23 2017
ETFs with exposure to Ocular Therapeutix, Inc. : January 9, 2017 Jan 09 2017
6 Major FDA Decisions and Biopharma Catalysts Coming in January and February Jan 06 2017
Ocular (OCUL) Reports Positive Phase III Data on Eye Drug Jan 05 2017
Ocular Therapeutix™ Announces Additional Successful Results for Phase 3 Clinical Trial of... Jan 04 2017
Ocular Therapeutix™ Announces Additional Successful Results for Phase 3 Clinical Trial of... Jan 04 2017
ETFs with exposure to Ocular Therapeutix, Inc. : December 30, 2016 Dec 30 2016
7 Key FDA Decisions and Catalysts Expected in January and February Dec 30 2016
How Ocular Therapeutix Inc (OCUL) Stacks Up Against Its Peers Dec 15 2016
OCULAR THERAPEUTIX, INC Files SEC form 8-K, Other Events Dec 14 2016
ETFs with exposure to Ocular Therapeutix, Inc. : December 8, 2016 Dec 08 2016
OCULAR THERAPEUTIX, INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other... Nov 30 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK